A Study Investigating the Utilization, Effectiveness and Quality of Life in Clinical Practice in Germany for Participants With Relapsing-remitting Multiple Sclerosis Treated With Ozanimod (Zeposia®)
Clinical trial NCT05335031 · COMPLETED
Trial details
- NCT number
- NCT05335031
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-03-03
- Primary completion
- 2025-06-30
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.